You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

Guidelines & Advice

About Guidelines Email Guidelines Team

Displaying Guidelines

10 Items

Adjuvant Systemic Chemotherapy for Stage II and III Colon Cancer Following Complete Resection

Document Status: Current
ID: 2-29
Version: 4

Updated

Feb 2024

An Endorsement of the 2021 Cancer Care Alberta Clinical Practice Guideline on Uveal Melanoma

Document Status: Current
ID: C50-CIDAP-1

Updated

Mar 2024

Comparison of PET/CT and PET/MR Imaging in Oncology

Document Status: Current
ID: ES PET 16
Version: 2

Updated

Apr 2024

Consensus Diagnostic and Prognostic Testing for Myelodysplastic Syndromes, Myeloproliferative Neoplasms, and Myelodysplastic/Myeloproliferative Neoplasms: Recommendations Report - 2024

Document Status: Current
Version: 1.0

Updated

Jan 2024

Fear of Cancer Recurrence Guideline

Document Status: Current
ID: GL 19-7

Updated

Mar 2024

Follow-up and Surveillance of Curatively Treated Lung Cancer Patients

Document Status: Current
ID: 26-3
Version: 2

Updated

Feb 2024

Management of Ductal Carcinoma in Situ of the Breast

Document Status: Current
ID: GL1-10
Version: 4

Updated

Jan 2024

Provincial Sarcoma Services Plan

Document Status: Current
ID: GL-C50-24
Version: 3

Updated

Jan 2024

Systemic Adjuvant Therapy for Adult Patients at High Risk for Recurrent Melanoma

Document Status: Current
ID: 8-1
Version: 6

Updated

Mar 2024

Systemic therapy for unresectable advanced or metastatic pancreatic and midgut neuroendocrine tumours

Document Status: Current
ID: GL 2-21
Version: 2

Updated

Mar 2024